Get in touch Contact us
Please type into the search bar above to begin your search
Please type three or more characters above to begin your search
Dr Deepa Narayanan
Dr Deepa Narayanan

Dr Deepa Narayanan

Consultant Chemical Pathology

MBBS MRCP FRCPATH

Make an enquiry

I have been a Consultant in Chemical Pathology and Metabolic medicine for 10 years.

I specialise in diagnosis and management of cholesterol disorders including Familial Hypercholesterolaemia including genetic testing, Lipoprotein a, management of cholesterol post heart attack/stent/bypass, statin side effects and intolerance and injectable treatments (PCSK9 inhibitors, Inclisiran).

I specialise in the diagnosis and management of Osteoporosis, vitamin D deficiency, Paget's disease and osteomalacia. I specialise in provision of interpretive and clinical advice on biochemical tests.

I have diagnosed and managed over 1,500 new patients referred for cholesterol management including 140 patients on injectable cholesterol therapies and over 1,250 patients referred for metabolic bone disease over a 10 year period, as a Chemical Pathology Consultant in the NHS service.

My clinical interests are Cholesterol management, including statin intolerance and injectable cholesterol lowering treatment, Lipid disorders including inherited conditions affecting cholesterol like Familial Hypercholesterolaemia, cardiovascular risk assessment, Osteoporosis, Vitamin D deficiency and metabolic bone disease.

I am the Clinical lead for the lipid clinic and Familial Hypercholesterolaemia services at Hull University Teaching Hospitals NHS Trust and led the implementation of the Familial Hypercholesterolaemia genetic testing service in 2017 in the Yorkshire and Humber region.

In addition, I am a clinical tutor at Hull University and involved in post graduate training in Chemical Pathology at Yorkshire and Humber deanery. My research interests are lipid disorders, lipid lowering treatments and Metabolic bone disorders. I am also the principal investigator for a multicentre cardiovascular outcome trials in Hull University Teaching Hospitals NHS Trust.

Read more...

Treatment information

Some of the principal treatments carried out by Dr Deepa Narayanan at Spire include:

Chemical pathology

Metabolic medicine

Other treatments

  • Biochemical test interpretation and clinical advice
  • Diagnosis and management of Osteoporosis
  • Disorders of Cholesterol, Lipoprotein a, Familial Hypercholesterolaemia
  • Injectable treatments (PCSK9 inhibitors, Inclisiran)
  • Management of cholesterol post heart attack/stent/bypass
  • Osteomalacia
  • Paget's disease
  • Statin side effects and intolerance
  • Vitamin D deficiency

Get in touch

146410
True
consultant
Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

We will use your personal information to process your enquiry. For further information, please see our privacy policy.


Additional information

Clinical biochemistry
Genetics
Osteoporosis
Metabolic bone diseases

Media Coverage

Nominee at the Golden Hearts Awards
June 2018

Hull University Teaching Hospitals NHS Trust

Telephone 01482 672412
Private secretary Rebecca Young | Emma Scott
Private secretary telephone 01482 660272
Private secretary email Rebecca.YOUNG@spirehealthcare.com | Emma.SCOTT2@spirehealthcare.com